Arch Therapeutics, Inc. announced that effective on the closing of the merger on June 26, 2013, the company has appointed Alan T. Barber as Chief Financial Officer. With his appointment, Mr. Barber will also serve as principal financial officer and principal accounting officer. Concurrent with the effectiveness of Mr. Barber's appointment, Terrence W. Norchi will relinquish his role as Interim Chief Financial Officer and continue in his roles as President, Chief Executive Officer and a director of the company.

Effective as of the closing of the Merger on June 26, 2013, Dr. Arthur Rosenthal was appointed as a director on Board of Directors, to fill a vacancy created by an increase to the size of the Board of Directors.